A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples